In a clinical trial of patients with a history of dry cough during ACE inhibitor therapy, 19.5% of trial subjects receiving valsartan and 19.0% of those receiving a thiazide diuretic experienced cough compared to 68.5% of those treated with an ACE inhibitor (P < 0.05).
Tutkimuksessa esiintyi yskää 19, 5%: lla valsartaania ja 19, 0%: lla tiatsididiureetteja saaneista potilaista, kun taas ACE: n estäjähoitoa saaneilla luku oli 68, 5% (p < 0, 05).